首站-论文投稿智能助手
典型文献
Risk factors of lymph node metastasis in rectal neuroendocrine tumors
文献摘要:
Objective The aim of this study was to investigate the risk factors of lymph node metastasis in rectal neuroendocrine neoplasms (RNENs). Methods We enrolled 168 patients with RNENs as the research object, and their clinicopathological and survival data were collected. The risk factors affecting lymph node metastasis were analyzed retrospectively, and independent risk factors affecting prognosis were evaluated. Results Analysis showed that age, tumor diameter, tumor function, grade, and T stage were correlated with lymph node metastasis (P < 0.05). Multiple logistic regression analysis showed that tumor size, grade, and T stage were independent risk factors for lymph node metastasis in patients with RNENs. Kaplan–Meier analysis showed that the 5-year overall survival (OS) of patients with lymph node metastasis was 40.0% (10/25), and that of patients without lymph node metastasis was 93.0% (133/143). The prognosis of RNENs patients with lymph node metastasis along with patients with large tumor diameter and high grade was poor. Cox multivariate analysis showed that tumor diameter (HR = 1.985, P = 0.008), grade (HR = 3.416, P = 0.004), T stage (HR = 2.413, P = 0.014), and lymph node metastasis (HR = 3.119, P = 0.000) were independent risk factors affecting the prognosis of patients with RNENs. Conclusion Tumor size, grade, and T stage are the main risk factors for lymph node metastasis and prognosis in patients with RNENs. These risk factors should be fully evaluated before surgery.
文献关键词:
作者姓名:
Donghong Liang;Zhennan Niu;Xiaofang Sun;Changjuan Meng;Zhuang Liu
作者机构:
Department of Endoscopy,Xingtai Third Hospital,Xintai 054099,China;Department of Pathology,Xingtai Third Hospital,Xintai 054099,China
引用格式:
[1]Donghong Liang;Zhennan Niu;Xiaofang Sun;Changjuan Meng;Zhuang Liu-.Risk factors of lymph node metastasis in rectal neuroendocrine tumors)[J].肿瘤学与转化医学(英文),2022(04):186-190
A类:
RNENs
B类:
Risk,factors,lymph,node,metastasis,rectal,neuroendocrine,tumors,Objective,aim,this,study,was,investigate,risk,neoplasms,Methods,We,enrolled,patients,research,object,their,clinicopathological,survival,data,were,collected,affecting,analyzed,retrospectively,independent,prognosis,evaluated,Results,Analysis,showed,that,diameter,function,grade,stage,correlated,Multiple,logistic,regression,analysis,size,Kaplan,Meier,year,overall,OS,without,along,large,high,poor,Cox,multivariate,Conclusion,Tumor,are,main,These,should,fully,before,surgery
AB值:
0.345066
相似文献
Coupling radiomics analysis of CT image with diversification of tumor ecosystem:A new insight to overall survival in stage Ⅰ-Ⅲ colorectal cancer
Yanqi Huang;Lan He;Zhenhui Li;Xin Chen;Chu Han;Ke Zhao;Yuan Zhang;Jinrong Qu;Yun Mao;Changhong Liang;Zaiyi Liu-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Department of Radiology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Guangdong Provincial Key Laboratory of Artificial Intelligence in Medical Image Analysis and Application,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;Department of Radiology,the Third Affiliated Hospital of Kunming Medical University,Yunnan Cancer Hospital,Yunnan Cancer Center,Kunming 650118,China;Department of Radiology,Guangzhou First People's Hospital,School of Medicine,South China University of Technology,Guangzhou 510180,China;Department of Radiology,the Affiliated Cancer Hospital of Zhengzhou University&Henan Cancer Hospital,Zhengzhou 450003,China;Department of Radiology,the First Affiliated Hospital of Chongqing Medical University,Chongqing 400042,China
Prognostic and incremental value of computed tomography-based radiomics from tumor and nodal regions in esophageal squamous cell carcinoma
Bangrong Cao;Kun Mi;Wei Dai;Tong Liu;Tianpeng Xie;Qiang Li;Jinyi Lang;Yongtao Han;Lin Peng;Qifeng Wang-Radiation Oncology Key Laboratory of Sichuan Province Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Biobank Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Thoracic Surgery Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Medical Imaging Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China;Department of Radiation Oncology,Sichuan Cancer Hospital&Institute,Sichuan Cancer Center,School of Medicine,University of Electronic Science and Technology of China,Chengdu 610041,China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。